NCT00258583

Brief Summary

The purpose of this study is to place past, current, and future medical record information into the UPMC Simmons Center for Interstitial Lung Disease Research Registry.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
112mo left

Started Oct 2003

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Oct 2003Jul 2035

Study Start

First participant enrolled

October 1, 2003

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

November 23, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 24, 2005

Completed
29.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2035

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2035

Last Updated

October 29, 2025

Status Verified

September 1, 2025

Enrollment Period

31.8 years

First QC Date

November 23, 2005

Last Update Submit

October 28, 2025

Conditions

Lung Diseases, Interstitial

Keywords

"Lung[A04.400]"

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population can be described as any adult being seen by a physician at the Simmons Center for interstitial lung disease who has been diagnosed with an Interstitial Lung Disease.

You may qualify if:

  • Adult patients who are seeking treatment at the UPMC Simmons Center for Interstitial Lung Disease
  • years of age or older

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michelle F MacPherson

Pittsburgh, Pennsylvania, 15213, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Lung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Kevin F Gibson, MD

    University of Pittsburgh - UPMC Simmons Center for Interstitial Lung Disease

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michelle F MacPherson, MAT

CONTACT

412-647-4537macphersonmj@upmc.edu

Michelle Meyers, BSN, RN

CONTACT

412-692-2149meyersma@upmc.edu

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

November 23, 2005

First Posted

November 24, 2005

Study Start

October 1, 2003

Primary Completion (Estimated)

July 1, 2035

Study Completion (Estimated)

July 1, 2035

Last Updated

October 29, 2025

Record last verified: 2025-09

Locations

US(1)